应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
02561 维昇药业-B
已收盘 12-17 16:08:10
37.600
+1.100
+3.01%
最高
39.140
最低
36.520
成交量
1.62万
今开
39.140
昨收
36.500
日振幅
7.18%
总市值
42.86亿
流通市值
42.86亿
总股本
1.14亿
成交额
60.75万
换手率
0.01%
流通股本
1.14亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
每日卖空追踪 | 维升药业-B 12月15日卖空量成交100股,卖空比例为0.71%
市场透视 · 12-15 16:30
每日卖空追踪 | 维升药业-B 12月15日卖空量成交100股,卖空比例为0.71%
每日卖空追踪 | 维升药业-B 12月11日卖空量成交600股,卖空比例为2.58%
市场透视 · 12-11
每日卖空追踪 | 维升药业-B 12月11日卖空量成交600股,卖空比例为2.58%
每日卖空追踪 | 维升药业-B 12月08日卖空量成交300股,卖空比例为3.7%
市场透视 · 12-08
每日卖空追踪 | 维升药业-B 12月08日卖空量成交300股,卖空比例为3.7%
维昇药业(02561)2025年11月股份变动月报:股本保持不变
公告速递 · 12-04
维昇药业(02561)2025年11月股份变动月报:股本保持不变
每日卖空追踪 | 维升药业-B 12月04日卖空量成交100股,卖空比例为1.22%
市场透视 · 12-04
每日卖空追踪 | 维升药业-B 12月04日卖空量成交100股,卖空比例为1.22%
每日卖空追踪 | 维升药业-B 12月02日卖空量成交3900股,卖空比例为4.18%
市场透视 · 12-02
每日卖空追踪 | 维升药业-B 12月02日卖空量成交3900股,卖空比例为4.18%
港股异动 | 维升药业-B(02561)再涨超12% 隆培促生长素即将获批 公司近期与东富龙达成战略合作
智通财经 · 12-02
港股异动 | 维升药业-B(02561)再涨超12% 隆培促生长素即将获批 公司近期与东富龙达成战略合作
维升药业-B(02561.HK)盘中涨超3%
每日经济新闻 · 12-01
维升药业-B(02561.HK)盘中涨超3%
港股异动 | 维升药业-B(02561)盘中涨超7% 公司核心产品隆培促生长素即将获批
智通财经 · 12-01
港股异动 | 维升药业-B(02561)盘中涨超7% 公司核心产品隆培促生长素即将获批
维升药业-B盘中异动 大幅拉升5.82%
市场透视 · 11-28
维升药业-B盘中异动 大幅拉升5.82%
每日卖空追踪 | 维升药业-B 11月27日卖空量成交700股,卖空比例为1.04%
市场透视 · 11-27
每日卖空追踪 | 维升药业-B 11月27日卖空量成交700股,卖空比例为1.04%
维升药业-B盘中异动 大幅上涨5.88%报30.960港元
市场透视 · 11-27
维升药业-B盘中异动 大幅上涨5.88%报30.960港元
每日卖空追踪 | 维升药业-B 11月25日卖空量成交300股,卖空比例为2.48%
市场透视 · 11-25
每日卖空追踪 | 维升药业-B 11月25日卖空量成交300股,卖空比例为2.48%
每日卖空追踪 | 维升药业-B 11月21日卖空量成交1000股,卖空比例为5.38%
市场透视 · 11-21
每日卖空追踪 | 维升药业-B 11月21日卖空量成交1000股,卖空比例为5.38%
安科生物:隆培促生长素审评已正常,此前沟通致暂停
新浪财经 · 11-20
安科生物:隆培促生长素审评已正常,此前沟通致暂停
每日卖空追踪 | 维升药业-B 11月20日卖空量成交200股,卖空比例为0.71%
市场透视 · 11-20
每日卖空追踪 | 维升药业-B 11月20日卖空量成交200股,卖空比例为0.71%
维升药业-B盘中异动 早盘股价大跌6.38%
市场透视 · 11-19
维升药业-B盘中异动 早盘股价大跌6.38%
决胜港股升浪·牛启东方2026——第十届智通财经资本市场年会邀您共赴资本盛宴
智通财经 · 11-18
决胜港股升浪·牛启东方2026——第十届智通财经资本市场年会邀您共赴资本盛宴
每日卖空追踪 | 维升药业-B 11月17日卖空量成交100股,卖空比例为0.18%
市场透视 · 11-17
每日卖空追踪 | 维升药业-B 11月17日卖空量成交100股,卖空比例为0.18%
每日卖空追踪 | 维升药业-B 11月14日卖空量成交100股,卖空比例为0.22%
市场透视 · 11-14
每日卖空追踪 | 维升药业-B 11月14日卖空量成交100股,卖空比例为0.22%
暂无数据
公司概况
公司名称:
维昇药业-B
所属市场:
SEHK
上市日期:
--
主营业务:
维昇药业是一家主要从事开发并商业化颠覆式内分泌疗法的投资控股公司。该公司的主要在研产品包括隆培促生长素、那韦培肽和帕罗培特立帕肽。隆培促生長素用于治疗3至17岁儿童生长激素缺乏症患者。那韦培肽是一款用于治疗2至10岁软骨发育不全儿童患者的疾病修复疗法。帕罗培特立帕肽是一款用于治疗成人甲状旁腺功能减退症的治疗方法。该公司处于研发后期、产品接近商业化。
发行价格:
--
{"stockData":{"symbol":"02561","market":"HK","secType":"STK","nameCN":"维昇药业-B","latestPrice":37.6,"timestamp":1765958890006,"preClose":36.5,"halted":0,"volume":16200,"delay":0,"floatShares":113999999,"shares":113999999,"eps":-1.946273,"marketStatus":"已收盘","change":1.1,"latestTime":"12-17 16:08:10","open":39.14,"high":39.14,"low":36.52,"amount":607456,"amplitude":0.071781,"askPrice":37.6,"askSize":200,"bidPrice":37,"bidSize":1000,"shortable":3,"etf":0,"ttmEps":-2.238552,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1766021400000},"marketStatusCode":5,"adr":0,"listingDate":1742486400000,"exchange":"SEHK","adjPreClose":36.5,"openAndCloseTimeList":[[1765935000000,1765944000000],[1765947600000,1765958400000]],"volumeRatio":0.461538,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02561/tweets","defaultTab":"tweets","newsList":[{"id":"2591862642","title":"每日卖空追踪 | 维升药业-B 12月15日卖空量成交100股,卖空比例为0.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2591862642","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591862642?lang=zh_cn&edition=full","pubTime":"2025-12-15 16:30","pubTimestamp":1765787430,"startTime":"0","endTime":"0","summary":"维升药业-B北京时间12月15日,跌1.3%,卖空量成交100股,较上一交易日减少50%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251215163500a44d41aa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251215163500a44d41aa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02561","BK1161"],"gpt_icon":0},{"id":"2590189510","title":"每日卖空追踪 | 维升药业-B 12月11日卖空量成交600股,卖空比例为2.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2590189510","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590189510?lang=zh_cn&edition=full","pubTime":"2025-12-11 16:30","pubTimestamp":1765441830,"startTime":"0","endTime":"0","summary":"维升药业-B北京时间12月11日,涨3.45%,卖空量成交600股,较上一交易日减少60%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251211163529a6991544&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251211163529a6991544&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02561"],"gpt_icon":0},{"id":"2590687073","title":"每日卖空追踪 | 维升药业-B 12月08日卖空量成交300股,卖空比例为3.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2590687073","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590687073?lang=zh_cn&edition=full","pubTime":"2025-12-08 16:30","pubTimestamp":1765182630,"startTime":"0","endTime":"0","summary":"维升药业-B北京时间12月08日,跌3.25%,卖空量成交300股,较上一交易日减少62.5%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251208163451a43afabb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251208163451a43afabb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02561"],"gpt_icon":0},{"id":"1122159333","title":"维昇药业(02561)2025年11月股份变动月报:股本保持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1122159333","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1122159333?lang=zh_cn&edition=full","pubTime":"2025-12-04 16:41","pubTimestamp":1764837716,"startTime":"0","endTime":"0","summary":"维昇药业(02561)于2025年12月4日发布截至2025年11月30日的股份变动月报。报告显示,公司法定股本维持在USD 50,000,普通股总数113,926,864股,与上月底相同,无新增发行及库藏股变动。\n报告期内,公司并未进行任何股份回购或注销操作。股权激励计划方面,董事会和股东曾于2025年3月8日批准最高可能发行2,399,500股股份,但截至11月末本月未有新股发行或库藏股份转让。\n公司表示将持续遵守香港联交所《上市规则》及相关法律规定。本次月报由执行董事卢安邦签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02561"],"gpt_icon":0},{"id":"2588838731","title":"每日卖空追踪 | 维升药业-B 12月04日卖空量成交100股,卖空比例为1.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588838731","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588838731?lang=zh_cn&edition=full","pubTime":"2025-12-04 16:30","pubTimestamp":1764837032,"startTime":"0","endTime":"0","summary":"维升药业-B北京时间12月04日,跌0.51%,卖空量成交100股,较上一交易日减少66.67%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204163457a4cc37fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204163457a4cc37fd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02561","BK1161"],"gpt_icon":0},{"id":"2588030023","title":"每日卖空追踪 | 维升药业-B 12月02日卖空量成交3900股,卖空比例为4.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588030023","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588030023?lang=zh_cn&edition=full","pubTime":"2025-12-02 16:30","pubTimestamp":1764664229,"startTime":"0","endTime":"0","summary":"维升药业-B北京时间12月02日,涨7.47%,卖空量成交3900股,较上一交易日增加875%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251202163437978b658c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251202163437978b658c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02561"],"gpt_icon":0},{"id":"2588965083","title":"港股异动 | 维升药业-B(02561)再涨超12% 隆培促生长素即将获批 公司近期与东富龙达成战略合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2588965083","media":"智通财经","labels":["corporation","productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588965083?lang=zh_cn&edition=full","pubTime":"2025-12-02 11:04","pubTimestamp":1764644686,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,维升药业-B(02561)再涨超12%,截至发稿,涨7.11%,报35.26港元,成交额190.82万港元。消息面上,安科生物近期披露合作进展,与维升药业合作的隆培促生长素即将获批。据悉,7月14日,安科生物宣布,公司与维升药业签订战略合作框架协议,共同推动隆培促生长素在中国市场的普及。值得注意的是,11月6日,第八届进博会期间,维升药业与国内制药装备龙头企业东富龙达成双腔冻干制剂技术战略合作,并与临港新片区管委会、临港集团物贸平台签署产业协同协议,标志着其在“全球创新、中国加速”的战略实践进一步落地。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1376389.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0251","02561","300171","BK1161"],"gpt_icon":0},{"id":"2588712212","title":"维升药业-B(02561.HK)盘中涨超3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588712212","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588712212?lang=zh_cn&edition=full","pubTime":"2025-12-01 09:59","pubTimestamp":1764554359,"startTime":"0","endTime":"0","summary":"每经AI快讯,维升药业-B(02561.HK)盘中涨超3%,截至发稿,涨3.64%,报31.88港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202512013578932295.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512013578932295.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["02561","BK1161"],"gpt_icon":0},{"id":"2588571236","title":"港股异动 | 维升药业-B(02561)盘中涨超7% 公司核心产品隆培促生长素即将获批","url":"https://stock-news.laohu8.com/highlight/detail?id=2588571236","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588571236?lang=zh_cn&edition=full","pubTime":"2025-12-01 09:49","pubTimestamp":1764553762,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,维升药业-B(02561)盘中涨超7%,截至发稿,涨3.64%,报31.88港元。消息面上,安科生物近期披露合作进展,与维升药业合作的隆培促生长素即将获批。据悉,7月14日,安科生物宣布,公司与维升药业签订战略合作框架协议,共同推动隆培促生长素在中国市场的普及;维升药业的核心产品隆培促生长素于2024年3月获中国国家药监局上市申请受理,预计于2025年下半年获批上市。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1375772.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02561","BK1161"],"gpt_icon":0},{"id":"2586270978","title":"维升药业-B盘中异动 大幅拉升5.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586270978","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586270978?lang=zh_cn&edition=full","pubTime":"2025-11-28 10:28","pubTimestamp":1764296913,"startTime":"0","endTime":"0","summary":"2025年11月28日早盘10时28分,维升药业-B股票出现异动,股价快速上涨5.82%。截至发稿,该股报32.020港元/股,成交量5400股,换手率0.00%,振幅6.81%。维升药业-B股票所在的生物技术行业中,整体跌幅为0.82%。其相关个股中,华康生物医学、拨康视云-B、维升药业-B涨幅较大,振幅较大的相关个股有拨康视云-B、派格生物医药-B、科笛-B,振幅分别为14.74%、11.43%、7.75%。维升药业-B公司简介:维升药业是一家主要从事开发并商业化颠覆式内分泌疗法的投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251128102833a4bf4a54&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251128102833a4bf4a54&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02561","BK1161","02592"],"gpt_icon":0},{"id":"2586908270","title":"每日卖空追踪 | 维升药业-B 11月27日卖空量成交700股,卖空比例为1.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586908270","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586908270?lang=zh_cn&edition=full","pubTime":"2025-11-27 16:30","pubTimestamp":1764232228,"startTime":"0","endTime":"0","summary":"维升药业-B北京时间11月27日,涨3.49%,卖空量成交700股,较上一交易日增加133.33%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511271637169782643f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511271637169782643f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02561"],"gpt_icon":0},{"id":"2586218827","title":"维升药业-B盘中异动 大幅上涨5.88%报30.960港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2586218827","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586218827?lang=zh_cn&edition=full","pubTime":"2025-11-27 09:34","pubTimestamp":1764207293,"startTime":"0","endTime":"0","summary":"2025年11月27日早盘09时34分,维升药业-B股票出现异动,股价快速上涨5.88%。截至发稿,该股报30.960港元/股,成交量1000股,换手率0.00%,振幅2.94%。资金方面,该股资金流入1.224万港元,流出9116港元。维升药业-B股票所在的生物技术行业中,整体跌幅为0.22%。其相关个股中,维升药业-B、博安生物、派格生物医药-B涨幅较大,振幅较大的相关个股有派格生物医药-B、药明巨诺-B、拨康视云-B,振幅分别为8.33%、7.17%、6.65%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251127093453a71404d3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251127093453a71404d3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02592","02561","BK1161"],"gpt_icon":0},{"id":"2586840179","title":"每日卖空追踪 | 维升药业-B 11月25日卖空量成交300股,卖空比例为2.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586840179","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586840179?lang=zh_cn&edition=full","pubTime":"2025-11-25 16:30","pubTimestamp":1764059430,"startTime":"0","endTime":"0","summary":"维升药业-B北京时间11月25日,股价较前一交易日持平,卖空量成交300股,较上一交易日减少40%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025112516343495192e3a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025112516343495192e3a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02561","BK1161"],"gpt_icon":0},{"id":"2585758161","title":"每日卖空追踪 | 维升药业-B 11月21日卖空量成交1000股,卖空比例为5.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2585758161","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585758161?lang=zh_cn&edition=full","pubTime":"2025-11-21 16:30","pubTimestamp":1763713831,"startTime":"0","endTime":"0","summary":"维升药业-B北京时间11月21日,跌4.56%,卖空量成交1000股,较上一交易日减少41.18%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251121163432a4b128f8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251121163432a4b128f8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02561"],"gpt_icon":0},{"id":"2585150040","title":"安科生物:隆培促生长素审评已正常,此前沟通致暂停","url":"https://stock-news.laohu8.com/highlight/detail?id=2585150040","media":"新浪财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585150040?lang=zh_cn&edition=full","pubTime":"2025-11-20 17:04","pubTimestamp":1763629440,"startTime":"0","endTime":"0","summary":"投资者提问:隆培促生长素的进展贵司有没有跟进?据我了解,隆培促生长素处于审批暂停状态,需要提交资料,合规方面无法通过,2025年已经拿不到批号了。贵司对维升药业的投资是否包含相关上市承诺?董秘回答(安科生物SZ300009):您好,之前维升药业与药审中心就生产细节进行沟通,所以审评处于暂停状态,目前相关沟通已经结束,审评开关已经打开,隆培促生长素处于正常审评中。谢谢您的关注。查看更多董秘问答>>免责声明:本信息由新浪财经从公开信息中摘录,不构成任何投资建议;新浪财经不保证数据的准确性,内容仅供参考。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511201806439510612f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511201806439510612f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02561","BK1161"],"gpt_icon":0},{"id":"2585168838","title":"每日卖空追踪 | 维升药业-B 11月20日卖空量成交200股,卖空比例为0.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2585168838","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585168838?lang=zh_cn&edition=full","pubTime":"2025-11-20 16:30","pubTimestamp":1763627430,"startTime":"0","endTime":"0","summary":"维升药业-B北京时间11月20日,跌1.31%,卖空量成交200股,较上一交易日减少92%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025112016362895103be1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025112016362895103be1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02561","BK1161"],"gpt_icon":0},{"id":"2584925085","title":"维升药业-B盘中异动 早盘股价大跌6.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584925085","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584925085?lang=zh_cn&edition=full","pubTime":"2025-11-19 09:51","pubTimestamp":1763517095,"startTime":"0","endTime":"0","summary":"2025年11月19日早盘09时51分,维升药业-B股票出现波动,股价急速跳水6.38%。截至发稿,该股报32.000港元/股,成交量8600股,换手率0.01%,振幅2.93%。维升药业-B股票所在的生物技术行业中,整体跌幅为0.27%。维升药业-B公司简介:维升药业是一家主要从事开发并商业化颠覆式内分泌疗法的投资控股公司。隆培促生长素用于治疗3至17岁儿童生长激素缺乏症患者。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251119095135950d5c7e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251119095135950d5c7e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02561","BK1161"],"gpt_icon":0},{"id":"2584023605","title":"决胜港股升浪·牛启东方2026——第十届智通财经资本市场年会邀您共赴资本盛宴","url":"https://stock-news.laohu8.com/highlight/detail?id=2584023605","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584023605?lang=zh_cn&edition=full","pubTime":"2025-11-18 08:53","pubTimestamp":1763427196,"startTime":"0","endTime":"0","summary":"由港美股第一资讯平台智通财经与中资海外私募基金一站式服务平台新智基金网联合主办,“冬日暖阳” 独家承办,S&P Global Market Intelligence、CITIZEN支持的“第十届智通财经资本市场年会”将于2025年12月3-5日联动深圳与香港两地举行。本届年会以\"决胜港股升浪·牛启东方2026\"为主题,设置六大核心议程,汇聚全球资本力量,共探宽松周期尾声的领涨赛道与中国资产长期增长潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1370226.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02627","02509","06996","02670","09911","01318","02488","02157","02177","02268","01228","06608","00363","02256","02096","00861","02167","02587","02453","00552","02171","01164","09959","02511","01333","00305","02431","00699","06609","02561","02420","01167","00382","00867","02142","00826","00196","02105","02279","03658","00003","09678","00302","00290","00855","09996","00604","06660","09878","06682"],"gpt_icon":0},{"id":"2584671821","title":"每日卖空追踪 | 维升药业-B 11月17日卖空量成交100股,卖空比例为0.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584671821","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584671821?lang=zh_cn&edition=full","pubTime":"2025-11-17 16:30","pubTimestamp":1763368229,"startTime":"0","endTime":"0","summary":"维升药业-B北京时间11月17日,涨1.15%,卖空量成交100股,较上一交易日持平更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251117163437a4a72e23&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251117163437a4a72e23&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02561","BK1161"],"gpt_icon":0},{"id":"2583635659","title":"每日卖空追踪 | 维升药业-B 11月14日卖空量成交100股,卖空比例为0.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2583635659","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583635659?lang=zh_cn&edition=full","pubTime":"2025-11-14 16:30","pubTimestamp":1763109032,"startTime":"0","endTime":"0","summary":"维升药业-B北京时间11月14日,跌4.18%,卖空量成交100股,较上一交易日增加100%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251114164018a4a11b3e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251114164018a4a11b3e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02561"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.visenpharma.com","stockEarnings":[{"period":"1week","weight":0.0495},{"period":"1month","weight":0.1054},{"period":"3month","weight":-0.1889},{"period":"6month","weight":-0.2551},{"period":"1year","weight":-0.4695},{"period":"ytd","weight":-0.4695}],"compareEarnings":[{"period":"1week","weight":-0.0078},{"period":"1month","weight":-0.0679},{"period":"3month","weight":-0.0622},{"period":"6month","weight":0.086},{"period":"1year","weight":0.2748},{"period":"ytd","weight":0.258}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"维昇药业是一家主要从事开发并商业化颠覆式内分泌疗法的投资控股公司。该公司的主要在研产品包括隆培促生长素、那韦培肽和帕罗培特立帕肽。隆培促生長素用于治疗3至17岁儿童生长激素缺乏症患者。那韦培肽是一款用于治疗2至10岁软骨发育不全儿童患者的疾病修复疗法。帕罗培特立帕肽是一款用于治疗成人甲状旁腺功能减退症的治疗方法。该公司处于研发后期、产品接近商业化。","exchange":"SEHK","name":"维昇药业-B","nameEN":"VISEN PHARMA-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"维昇药业-B(02561)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供维昇药业-B(02561)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"维昇药业-B,02561,维昇药业-B股票,维昇药业-B股票老虎,维昇药业-B股票老虎国际,维昇药业-B行情,维昇药业-B股票行情,维昇药业-B股价,维昇药业-B股市,维昇药业-B股票价格,维昇药业-B股票交易,维昇药业-B股票购买,维昇药业-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"维昇药业-B(02561)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供维昇药业-B(02561)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}